Since the publication of the CRASH-2 and MATTERs trials, new evidence has emerged regarding the use of tranexamic acid (TXA) in trauma patients. While CRASH-2 demonstrated a reduction in mortality with TXA use in bleeding trauma patients, subsequent studies like CRASH-3, STAAMP, and PATCH have provided additional insights into its efficacy and safety, particularly in specific trauma populations such as those with traumatic brain injury. However, these newer findings have not been widely integrated into clinical practice. This presentation will review recent data from these trials to determine how the latest evidence should inform the optimal use of TXA in trauma care
- Provider:Ascension
- Activity Link: https://ascension-ce-cme.cloud-cme.com/
- Start Date: 2024-11-26 06:00:00
- End Date: 2024-11-26 06:00:00
- Credit Details: IPCE Credits: 0.75 hours
AAPA Category 1 Credit™️: 0.75 hours
AMA PRA Category 1 Credit™️: 0.75 hours
Nursing: 0.75 hours
Pharmacy: 0.75 hours - MOC Credit Details: ABS - 0.75 Point; Credit Type(s): Accredited CME (ABS)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Surgery
Subscribe
Login
0 Comments
Oldest